Kristin V. T. Engebretsen

Attenuated development of cardiac fibrosis in left ventricular pressure overload by SM16, an orally active inhibitor of ALK5

Kristin V. T. Engebretsen, Kristine Skårdal, Sigrid Bjørnstad et al. · Journal of Molecular and Cellular Cardiology · 2014 · 107 citations

Active Inhibitor, Fibrosis, Heart Failure +11

Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli

Kristin V. T. Engebretsen, Ida G. Lunde, Mari E. Strand et al. · FEBS Journal · 2013 · 103 citations · Full text

The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling

Kine Andenæs, Ida G. Lunde, Naiyereh Mohammadzadeh et al. · PLoS ONE · 2018 · 76 citations · Full text

Cardiac Muscle, Heart Failure, Pathology +17

The extracellular matrix proteoglycan lumican improves survival and counteracts cardiac dilatation and failure in mice subjected to pressure overload

Naiyereh Mohammadzadeh, Ida G. Lunde, Kine Andenæs et al. · Scientific Reports · 2019 · 63 citations · Full text

Lack of collagen VIII reduces fibrosis and promotes early mortality and cardiac dilatation in pressure overload in mice†

Biljana Skrbic, Kristin V. T. Engebretsen, Mari E. Strand et al. · Cardiovascular Research · 2015 · 60 citations · Full text